✦ LIBER ✦

Primary central nervous system lymphoma as a variant of Richter's syndrome in two patients with chronic lymphocytic leukemia

✍ Scribed by Brin P. O'neill; Thomas M. Habermann; Peter M. Banks; Judith R. O'Fallon; John D. Earle

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 742 KB
Volume: 64
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890915)64:6<1296::aid-cncr2820640621>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary central nervous system lymphoma

Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiation

✍ Jeffrey D. Goldstein; Barbi Kaplan; Lawrence Davis; Dennis W. Dickson; Josefina 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 1002 KB

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Kacey O'Rourke; Kirk Morris; Glen A. Kennedy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Matthew Hellmann; Jeffrey A. Barnes; Peter Hammerman; Christ 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

Reply to intravenous methotrexate as cen

Reply to intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Ephraim P. Hochberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

I read with great interest the article by Cooperberg and coworkers 1 studying survival rates in differently treated men with early prostate cancer. In this study, patients who underwent radical prostatectomy had a substantially decreased disease-specific mortality, particularly in the higher-risk gr